CONFORMATIONALLY CONSTRAINED ANALOGS OF DIACYLGLYCEROL - INTERACTION OF GAMMA-LACTONES WITH THE PHORBOL ESTER RECEPTOR OF PROTEIN-KINASE-C

被引:59
作者
TENG, K
MARQUEZ, VE
MILNE, GWA
BARCHI, JJ
KAZANIETZ, MG
LEWIN, NE
BLUMBERG, PM
ABUSHANAB, E
机构
[1] NCI, DIV CANC TREATMENT, DEV THERAPEUT PROGRAM, MED CHEM LAB, BETHESDA, MD 20892 USA
[2] UNIV RHODE ISL, DEPT MED CHEM, KINGSTON, RI 02881 USA
[3] UNIV RHODE ISL, DEPT CHEM, KINGSTON, RI 02881 USA
关键词
D O I
10.1021/ja00029a039
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Four 2-deoxy-erythro-1,4-lactones in the D- and L-series and the four corresponding 2-deoxy-threo-1,4-lactones, bearing myristic acid acyl groups at either primary or secondary alcohol functions, were synthesized from L-ascorbic and D-isoascorbic acids. These eight pentonolactones which represent all possible isomers in this series were designed as rigid analogues of 1,2-diacylglycerol (DAG). The inhibition by these compounds of the binding of [H-3]phorbol-12,13-dibutyrate to protein kinase C (PK-C) demonstrated the importance in this context of stereochemistry and particularly of the orientation of the fatty acid side chain. The most effective inhibitor (13d, K(i) = 2.3-mu-M) has a fixed conformation which is presumed to be similar to the conformation adopted by DAG when binding to PK-C. A three-point attachment model which has been previously used to rationalize the similar behavior of DAG and phorbol esters was extended to include additional points of equivalence between these two PK-C agonists. This extended model addresses the disposition of the lipophilic myristic acid side chain and the orientation of the lactone carbonyl group which functions as a hydrogen bond acceptor. In this new model, the most active isomer 13d provides the best fit of the eight pentonolactones to phorbol myristate acetate.
引用
收藏
页码:1059 / 1070
页数:12
相关论文
共 54 条
  • [1] THE CHEMISTRY OF L-ASCORBIC AND D-ISOASCORBIC ACIDS .1. THE PREPARATION OF CHIRAL BUTANETRIOLS AND BUTANETETROLS
    ABUSHANAB, E
    VEMISHETTI, P
    LEIBY, RW
    SINGH, HK
    MIKKILINENI, AB
    WU, DCJ
    SAIBABA, R
    PANZICA, RP
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (11) : 2598 - 2602
  • [2] ANDERSON WB, 1985, PHOSPHOLIPIDS CELLUL, V2, P127
  • [3] BENZYLIDENE ACETALS OF THE D-RIBONOLACTONES - A STRUCTURAL REASSESSMENT
    BAGGETT, N
    BUCHANAN, JG
    FATAH, MY
    LACHUT, CH
    MCCULLOUGH, KJ
    WEBBER, JM
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1985, (24) : 1826 - 1827
  • [4] BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111
  • [5] BISHOP WR, 1986, J BIOL CHEM, V261, P6993
  • [6] BLUMBERG PM, 1988, CANCER RES, V48, P1
  • [7] BONI LT, 1985, J BIOL CHEM, V260, P819
  • [8] X-RAY STRUCTURE ANALYSIS OF NEOPHORBOL, C31H3509BR, AND PHORBOL, C20H2806
    BRANDL, F
    ROHRL, M
    ZECHMEIS.K
    HOPPE, W
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL CRYSTALLOGRAPHY AND CRYSTAL CHEMISTRY, 1971, B 27 (SEP15): : 1718 - &
  • [10] CANTLEY L, 1987, ANTI-CANCER DRUG DES, V2, P129